Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.225
Bid: 1.15
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.15 (13.043%)
Open: 1.20
High: 1.30
Low: 1.30
Prev. Close: 1.225
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

2 Jul 2008 16:26

RNS Number : 1804Y
Chamberlin PLC
02 July 2008
 



CHAMBERLIN PLC (THE "COMPANY")

Directors' Dealings

The Company announces that on 2 July 2008, awards over ordinary shares with a nominal value of 25 pence each in the Company ("Shares") were made under the rules of the Chamberlin & Hill Performance Share Plan and the Chamberlin & Hill Share Option Plan to Directors of the Company, as follows:

Chamberlin & Hill Performance Share Plan ("PSP")

Director

Number of EMI options over Shares awarded 

Number of unapproved options over Shares awarded 

Total revised number of Shares over which options are held under the PSP

Tim Hair

11,940

14,925

76,860

Mark Bache

17,910

0

56,367

Adam Vickery

13,432

0

47,275

Under the PSP, awards are structured as nil-cost options granted under the Enterprise Management Incentives Scheme ("EMI") contained in Schedule 5 to the Income Tax (Earnings and Pensions) Act 2003. To the extent that an award is granted under the Plan in excess of the EMI individual limit of £120,000, the excess is treated as an Unapproved Option which is subject to the same terms as the EMI Option.

No consideration was paid for the grant of the Options.

The vesting of an Option is subject to the continued employment of the participant and the satisfaction of a performance condition set by the Remuneration Committee of the Company. The Option will normally become exercisable on the third anniversary of the date of grant subject to the satisfaction of a performance condition set by the Remuneration Committee of the Company.

To the extent that an EMI Option or any part of an EMI Option becomes exercisable, it remains exercisable until the tenth anniversary of the date of grant. To the extent that an Unapproved Option or any part of an Unapproved Option becomes exercisable, it remains exercisable for a period of 12 months from the date of vesting.

Chamberlin & Hill Share Option Plan ("SOP")

Director

Number of options over Shares awarded 

Total revised number of Shares over which options are held under the SOP

Tim Hair

303,680

505,962

Mark Bache

147,237

250,971

No consideration was paid for the grant of options under the SOP, which are structured as market value options.

The options will normally become exercisable in three equal tranches on each of the third, fourth and fifth anniversaries of the date of grant subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. To the extent that an option or any part of an option becomes exercisable, it remains exercisable until the tenth anniversary of the date of grant.

The option price payable by each participant on the exercise of his option is 163p.

The Company was informed of the above transactions under the PSP and SOP on 2 July 2008.

Enquiries:

Chamberlin plc

Tom Brown, Chairman 01922 707100

Tim Hair, Chief Executive  01922 707100

Landsbanki Securities (UK) Limited

Tom Hulme, NOMAD 020 7426 9000

Citigate Dewe Rogerson

Toby Mountford 07710 356611

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSIFIESASEEW
Date   Source Headline
22nd Apr 20247:00 amRNSHolding(s) in Company
16th Apr 202410:43 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSTrading Update
5th Apr 20247:00 amRNSBoard Changes
3rd Apr 20244:12 pmRNSHolding(s) in Company
27th Feb 20241:24 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSCompletion of Sale of Petrel Limited
21st Feb 202412:01 pmRNSSale of Petrel Limited
21st Feb 202412:00 pmRNSInterim Results
18th Jan 20243:34 pmRNSHolding(s) in Company
16th Jan 20241:20 pmRNSHolding(s) in Company
11th Jan 20246:26 pmRNSHolding(s) in Company
10th Jan 20245:12 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSPlacing and Subscription
3rd Jan 20242:41 pmRNSResult of AGM and Trading Update
15th Dec 20237:00 amRNSCorporate Update
30th Nov 20231:40 pmRNSFinal Results
28th Nov 20235:00 pmRNSHolding(s) in Company
24th Oct 20234:22 pmRNSChange of Nominated Adviser and Joint Broker
18th Oct 20232:14 pmRNSHolding(s) in Company
27th Jul 20232:00 pmRNSGrant of Share Options
24th Jul 202310:17 amRNSDirector/PDMR Shareholding
22nd Jun 20232:03 pmRNSMajor Contract Win
8th Jun 20237:00 amRNSHolding(s) in Company
26th May 20237:00 amRNSPlacing and Subscription
2nd May 20233:42 pmRNSSale and Leaseback of Walsall Property
28th Feb 20237:00 amRNSHalf-year Report
2nd Feb 20234:14 pmRNSHolding(s) in Company
1st Feb 20235:24 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSHolding(s) in Company
26th Jan 202311:53 amRNSPlacing and Subscription
19th Dec 202211:00 amRNSHolding(s) in Company
16th Dec 20221:49 pmRNSCorporate Update
30th Nov 202211:37 amRNSResult of AGM
30th Nov 20227:00 amRNSAGM Statement and Trading Update
21st Nov 20222:44 pmEQSChamberlin PLC 'left no stone unturned' during return to profit
7th Nov 20225:31 pmRNSPosting of Annual Report and Notice of AGM
4th Nov 202212:23 pmRNSFinal Results
31st Oct 202211:32 amRNSAnnouncement re: Full year results
29th Sep 20227:00 amRNSAnnouncement re: Full year results
29th Jul 20227:00 amRNSIssue of Equity and Director/PDMR Shareholding
25th Jul 20225:30 pmRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSHolding(s) in Company
8th Jul 20225:20 pmRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSFull Year Trading Update and Notice of Results
8th Jun 20229:42 amRNSDirector/PDMR Shareholding
5th May 20221:13 pmRNSSale and Leaseback of RDC Property
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20222:30 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.